¿Perdió su Contraseña?
Regístrese Gratuitamente!
Siguenos en:
Siguenos en Facebook Siguenos en Twitter


Enfermedades y tratamientos : Financing uterus transplants: The United States context.
Enviado por Biblio on 13/9/2018 7:04:00 (132 Lecturas)

Blake VK. Financing uterus transplants: The United States context. Bioethics. 2018 Aug 31. doi: 10.1111/bioe.12506. [Epub ahead of print]

Disponible en:

The first baby has successfully been born by uterus transplantation (UTx) in the United States and the procedure is swiftly becoming a viable clinical option for patients with uterine factor infertility (UFI). This raises a practical ethical question: should health insurers finance UTx and what issues should they consider in coming to this decision? The article lays forth some of the factors that shape the decision over whether to finance UTx in the United States, including what procedures must be covered, whether UTx is more like organ transplantation or infertility treatment (which are treated differently in the United States), and the benefits and alternatives of the procedure. Then, the article explores arguments around why UTx should be financed, or at least considered along with other important medical needs. The paper argues that UTx ought to be considered along with other competing claims for healthcare services. In countries that generously cover other infertility services, it may logically follow that medical services that enable gestation should be insured when the healthcare system covers services to conceive. In the United States, however, many groups have long suffered inadequate access to medical care, in the context of infertility and more broadly. U.S. healthcare may need to be made more widely equitable, before covering UTx is seen as financially or politically possible.

Página de Impresión Amigable Enviar este artículo a un amigo
Los comentarios son propiedad de quien los envió. No somos responsables de su contenido.
Envió Hilo
Bioètica i Debat Ediciones SL